# dopamine replacement pathway 

#Taper-plan.md

**Title**: *Structured Taper: From 550 mg Methamphetamine to Bupropion*  
**Author**: Andrew Egerszegi  
**Purpose**: A personalized, neuroprotective strategy to shift from high-dose MA use to Bupropion with minimal risk of seizures, anhedonia, or cognitive dullness.

---

## 🧠 Overview

This plan moves you off **550 mg/day Methamphetamine** and transitions you onto **Bupropion 150–300 mg SR** within **14–21 days**, using supportive compounds and optional Keppra for seizure buffering.

---

## 🧪 Day 1–3: Prime the Brain

| Compound           | Dose           | Notes                                              |
|--------------------|----------------|-----------------------------------------------------|
| MA                 | 550 mg total   | Usual split across day                             |
| Bupropion          | 0 mg           | Do **not** start yet                               |
| NAC                | 1200 mg/day    | AM/PM dosing — neuroprotection                     |
| DLPA or Tyrosine   | 1000 mg/day    | Morning only — dopamine support                    |
| Magnesium + B6     | As per label   | Prevents rebound excitotoxicity                    |
| Metoprolol (if needed) | 25–50 mg     | Controls HR, BP, and anxiety                       |

> Optional: Start **Keppra 250 mg BID** if you have seizure risk

---

## 🧬 Day 4–7: Begin Bupropion + First Cut

| Compound           | New Protocol                                     |
|--------------------|--------------------------------------------------|
| MA                 | ↓ to **450 mg/day** (about 20% reduction)        |
| Bupropion          | **150 mg SR AM**                                 |
| DLPA/Tyrosine      | Only if mood dips — stop if overstimulated       |

> If any agitation or insomnia: hold dose at 150 mg Bupropion longer  
> Stay hydrated and consistent — **no drug-hopping**

---

## 🔁 Day 8–12: Second Cut + Stabilize

| Compound           | Adjustments                                      |
|--------------------|--------------------------------------------------|
| MA                 | ↓ to **300–350 mg/day**                          |
| Bupropion          | Maintain **150 mg SR**                           |
| Keppra             | Optional, maintain 250–500 mg BID                |

> You may feel unusually calm or foggy — this is dopamine rebound blunting. NAC, protein meals, and sleep help here.

---

## ⚖️ Day 13–17: Third Cut + Optional Bupropion Increase

| Compound           | Strategy                                          |
|--------------------|--------------------------------------------------|
| MA                 | ↓ to **200 mg/day or less**                      |
| Bupropion          | ↑ to **300 mg SR** (split: 150 AM / 150 PM)      |

> Avoid stacking Bupropion PM if it ruins sleep — use single AM dose until stable.

---

## ✅ Day 18–21: Final MA Reduction

| Compound           | Goal                                              |
|--------------------|--------------------------------------------------|
| MA                 | ↓ to **50–100 mg/day or stop entirely**          |
| Bupropion          | Maintain **300 mg SR** or drop back to 150 mg    |

> You’ve transitioned. Cravings may linger but neurodrive returns slowly. Stay clean, hydrated, and avoid "test doses".

---

## 🧘 Maintenance Strategy

| Support Compound     | Use Case                         |
|----------------------|----------------------------------|
| NAC                  | Daily for 30+ days               |
| DLPA or Tyrosine     | Pulse on low-motivation days     |
| Magnesium            | Bedtime calming + nerve repair   |
| Ashwagandha          | Cortisol control + sleep support |
| Keppra               | Taper off after 30 days, if used |

---

## 🧠 Philosophy

> *“Tapering isn’t subtraction — it’s reallocation of drive into places that don’t destroy you.”*  
> – Andrew Egerszegi

---

## 📂 Suggested Repo Location
